TSTickerStarGet alerts

INBS preliminary proxy seeks votes on equity plan expansion and Series N-2 warrants

INBS's preliminary proxy sets a virtual annual meeting for December 3, 2026 and asks stockholders to approve eight proposals, including a 221,000-share expansion of the 2019 Long Term Incentive Plan and authorization for up to 2,036,659 shares upon exercise of the Series N-2 warrants. The Series N-2 warrants have a $2.33 exercise price and would generate approximately $4,745,415 in gross proceeds if fully exercised, while diluting existing stockholders. The August 2026 private placement raised approximately $5.0...

Share this story

Key takeaways

  • Annual meeting: The virtual meeting is scheduled for December 3, 2026 at 4:00 p.m. Eastern Time, with October 13, 2026 as the record date.

  • Director and auditor votes: All four current directors were nominated for re-election, and stockholders are asked to ratify UHY LLP for the fiscal year ending June 30, 2027.

  • 2019 Plan share reserve: Stockholder approval would increase the reserve from 179,500 shares to 400,500 shares, an increase of 221,000 shares.

  • 2019 Plan governance: The amendment would impose a one-year minimum vesting requirement, prohibit dividends on unvested awards, and reset the annual non-employee director award limit from 5,000 to 10,000 shares.

  • Nasdaq warrant approval: Stockholders are asked to authorize issuance of up to 2,036,659 shares upon exercise of Series N-2 warrants priced at $2.33 per share, with potential gross exercise proceeds of approximately $4,745,415.

  • August private placement: The completed placement generated approximately $5.0 million in gross proceeds, and the company said it intends to use the net proceeds for working capital and general corporate purposes.

  • Equity ownership: Alyeska Master Fund, L.P. beneficially owned 9.99% as of October 13, 2026, while 12,045,102 shares were issuable on outstanding warrants with a weighted-average exercise price of $3.64 per share.

Key metrics

Common shares outstandingOctober 13, 2026
3,316,803 shares
Current 2019 Plan share reserveOctober 13, 2026
179,500 shares
Proposed 2019 Plan share reserveIf approved at the December 3, 2026 Annual Meeting
400,500 shares
Additional 2019 Plan shares requestedIf approved at the December 3, 2026 Annual Meeting
221,000 shares
2019 Plan shares currently available for issuanceOctober 13, 2026
3,265 shares
Proposed non-employee director annual award limitIf approved at the December 3, 2026 Annual Meeting
10,000 shares per director per fiscal year
Series N-2 warrant sharesPending stockholder approval
2,036,659 shares
Series N-2 exercise pricePending stockholder approval
$2.33 per share

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow INBS in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert